SLC1A5 and prostate carcinoma: ASCT2 is upregulated in various cancers such as hepatocellular carcinoma, non-small cell lung cancer (NSCLC), breast cancer, colorectal cancer, gastric cancer, clear cell renal cell carcinoma, and prostate cancer [54,55,56,57,58,59,60].